Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD)

BACKGROUND: Hepatic fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) independently predicts mortality. Given liver biopsy’s invasive nature, non-invasive method to assess hepatic steatosis and fibrosis provides NAFLD risk stratification algorithm in clinical practice. NAFLD fibros...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Open Gastroenterol
Autors principals: Golabi, Pegah, Stepanova, Maria, Pham, Huong T, Cable, Rebecca, Rafiq, Nila, Bush, Haley, Gogoll, Trevor, Younossi, Zobair M
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2018
Matèries:
Hepatology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5873539/
https://ncbi.nlm.nih.gov/pubmed/29607054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgast-2018-000198
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars